Research results from Institute Krems Bioanalytics of IMC Krems and Takeda will help to treat patients suffering from hemophilia A more effectively. Krems, Austria, 22. November 2022: Immune responses against Factor VIII, which is
WeiterlesenHemophilia Treatment: New Insights Contribute to Minimize or Eliminate Side Effects in the Future
